Does pregabalin cause constipation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 21, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Does Pregabalin Cause Constipation?

Yes, pregabalin causes constipation as a recognized adverse effect, occurring in approximately 8.2% of patients compared to 5.7% with placebo according to FDA labeling data. 1

Mechanism and Clinical Significance

Pregabalin affects calcium channels in the enteric nervous system, which may reduce peristaltic activity in a manner similar to opioid effects on the gastrointestinal tract. 2 This mechanism explains why constipation can be a dose-dependent and clinically significant adverse effect in some patients.

Incidence and Severity

  • FDA-approved labeling reports constipation in 8.2% of pregabalin-treated patients versus 5.7% on placebo. 1
  • Clinical experience from tertiary epilepsy centers demonstrates that severe and disabling constipation can occur in approximately 7.5% of patients, typically developing within 1-2 weeks of initiating pregabalin. 3
  • Constipation severity is dose-dependent, with higher doses (300 mg/day) causing more severe symptoms than lower doses (150 mg/day). 4
  • In some cases, constipation is severe enough to require drug withdrawal, accounting for 6.3% of pregabalin discontinuations. 3

Risk Factors

Patients with pre-existing gastrointestinal motility disorders are at higher risk for developing pregabalin-induced constipation. 2 Elderly patients appear particularly vulnerable to this adverse effect, especially when combined with other dose-related side effects. 4

Clinical Management Algorithm

First-Line Interventions:

  • Ensure adequate hydration and encourage physical activity when appropriate. 2
  • Dietary interventions with adequate fiber intake may be helpful for patients with sufficient fluid intake. 2

For Persistent Constipation:

  • Osmotic laxatives such as polyethylene glycol (PEG) 17g mixed in 8 ounces of water are recommended as first-line pharmacologic treatment. 2
  • Stimulant laxatives like bisacodyl or senna may be needed for more severe cases. 2

For Refractory Cases:

  • Dose reduction should be strongly considered, as symptoms typically improve or resolve with lower doses. 3, 4
  • Drug discontinuation may be necessary if constipation remains severe despite management, as symptoms are entirely reversible upon pregabalin withdrawal. 3

Important Clinical Pitfalls

Do not overlook this adverse effect. Severe pregabalin-induced constipation can lead to multiple unnecessary investigations and procedures if clinicians are unaware that this is an entirely reversible side effect. 3 The constipation can be marked and disabling, not merely mild or moderate as previously reported in earlier literature.

Postmarketing surveillance has identified life-threatening complications when pregabalin is co-administered with medications that produce constipation (such as opioid analgesics), including intestinal obstruction and paralytic ileus. 1 This represents a critical drug interaction requiring heightened vigilance.

Comparison to Other Medications

Pregabalin and gabapentin share similar constipation profiles, as both are calcium channel α2-δ ligands with common side effects including dizziness, somnolence, dry mouth, and constipation. 5 When pregabalin is discontinued due to constipation, substituting gabapentin may result in similar gastrointestinal adverse effects. 6

References

Guideline

Pregabalin-Induced Constipation Mechanism and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Possible heart failure associated with pregabalin use: case report.

Agri : Agri (Algoloji) Dernegi'nin Yayin organidir = The journal of the Turkish Society of Algology, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.